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Abstract 
Background 
Substance abuse, a common problem worldwide, has been found to be prevalent among patients suffering from Schizophrenia1, 4.
Pakistan, a South Asian developing country with a population of 150 million, is no exception. 1, 4 
There is a dearth of locally published literature on the prevalence of substance abuse amongst schizophrenic patients and 
especially in-patients.  
The present study was done keeping in view these observations with the aim to present findings in a psychiatric inpatient sample
at a tertiary care hospital in Karachi, Pakistan. 
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Introduction
Substance abuse is defined as a maladaptive pattern of substance use leading to clinically significant impairment or 
distress, wherein the person may also suffer from tolerance and withdrawal 2 
Schizophrenia is a severe brain disease resulting in substantial loss of reproductive fitness in the past, and it is has a 
lifetime prevalence close to 1% worldwide and across cultures. It is clear that many individuals who are genetically 
vulnerable to schizophrenia do not express it, and that schizophrenia is multifactorial, involving genes, 
environmental factors, their interactions, and hypothesized epigenetic factors. . 3 
Studies conducted worldwide since the early1990s have found a wide range of psychoactive substance abuse 
prevalence rates, with male gender and younger age as the primary correlates. Although, less certainty exists 
regarding substance abuse as an independent risk factor for schizophrenia and its further impact on illness course.4
There is substantial evidence for substance misuse being a major risk factor for violence and aggression in patients 
with major mental disorder, especially schizophrenia 19, 20, 21, 22, 23   and seems to be associated with greater use of in-
patient services 21
Method
Medical records of 50 in-patients, who were admitted with the primary diagnosis of Schizophrenia in the last six 
months, were reviewed by the author. 
Result
There were 46 male and 4 female patients. 
40% patients (n=20) were in the age range of 21-30 years. 
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46% (n=23) of the patients were married at the time of admission, only 8% (n=4) of the sample had no formal 
education. 
 Interestingly, only the records of male patients reported a history of substance abuse (n=26) along with their 
principal diagnosis of schizophrenia. The most commonly reported psychoactive substance was Alcohol (n=15). 
Cannabis was noted to be the second most commonly used psychoactive substance (n=11). 
Discussion
The results show that 52% of admitted schizophrenics are also substance abusers. This is somewhat higher in 
comparison with worldwide published data that indicates a lifetime prevalence of drug abuse among first-episode 
cases of schizophrenia upto 35% 6,15,16,17, and that too more common in male patients,  6, 15,16,17,18 similar to this 
study. 
A recent Prospective case control study conducted in Karachi has reported the mean age of onset of schizophrenia to 
be 23.96 years in females and 24.13 years in males. 24 In the present study, majority of the patients were also young. 
These findings seem to indicate that substance abuse in the early course of illness determines an earlier onset of 
schizophrenia and could play a role in increasing the severity of psychosis. Therefore persons incurring a risk of 
schizophrenia may be warned of the possible relation between substances and psychosis and should be counseled 
against the use of them.
In the present study, 54% of the sample was not married at the time of admission in the psychiatry ward. As Gillis et 
al 25 has also pointed out, the high-risk individual in Pakistan, as in the United States, is one with ready access to 
drugs and the social inducements to use them while lacking bonds with societal institutions or value systems which 
might mitigate against drug use. Further research regarding the psycho-social rehabilitation of the schizophrenic 
patients post-admission, would be helpful in determining the fate of such patients especially those without a primary 
support system. 26
In conclusion, the present study indicates that substance abuse is frequent among in-patients with schizophrenia, and 
could have a considerable effect on symptom presentation; it also seems to precipitate the onset of schizophrenia at 
an earlier age. These findings, which are in line with other recently published data, underline the need to act early on 
substance abuse. People at risk of schizophrenia should be warned of the possible relationship between substance 
abuse and psychosis, and counseled against the use of it. Further research is recommended as the next step for the 
development of risk management strategies and the evaluation of treatment in people with dual-diagnosis. 
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